You are here:
| Reference : Escherichia coli virulence factors |
| Scientific journals : Article | |||
| Life sciences : Veterinary medicine & animal health | |||
| http://hdl.handle.net/2268/135714 | |||
| Escherichia coli virulence factors | |
| English | |
Mainil, Jacques  [Université de Liège - ULg > Département des maladies infectieuses et parasitaires > Bactériologie et pathologie des maladies bactériennes >] | |
| 2013 | |
| Veterinary Immunology and Immunopathology | |
| Elsevier Science | |
| 152 | |
| 2-12 | |
| International | |
| 0165-2427 | |
| Amsterdam | |
| The Netherlands | |
| [en] Escherichia coli ; virulence ; pathotypes | |
| [en] Escherichia coli was described in 1885 by a German pediatrician, Theodor Escherich, in
the faeces of a child suffering diarrhoea. In 1893, a Danish veterinarian postulated that the E. coli species comprises different strains, some being pathogens, others not. Today the E. coli species is subdivided into several pathogenic strains causing different intestinal, urinary tract or internal infections and pathologies, in animal species and in humans. Since this congress topic is the interaction between E. coli and the mucosal immune system, the purpose of this manuscript is to present different classes of adhesins (fimbrial adhesins, afimbrial adhesins and outer membrane proteins), the type 3 secretion system, and some toxins (oligopeptide, AB, and RTX pore-forming toxins) produced by E. coli, that can directly interact with the epithelial cells of the intestinal, respiratory and urinary tracts. | |
| Researchers ; Professionals ; Students | |
| http://hdl.handle.net/2268/135714 |
| File(s) associated to this reference | ||||||||||||||
|
Fulltext file(s):
| ||||||||||||||
All documents in ORBi are protected by a user license.
